First National Trust CO Becton Dickinson & CO Transaction History

First National Trust CO

  • $2.62 Billion
  • Q4 2024

A detailed history of First National Trust CO transactions in Becton Dickinson & CO stock. As of the latest transaction made, First National Trust CO holds 1,452 shares of BDX stock, worth $326,409. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,452
Previous 1,487 2.35%
Holding current value
$326,409
Previous $358,000 8.1%
% of portfolio
0.01%
Previous 0.01%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 10, 2025
SELL
$220.02 - $243.75 $7,700 - $8,531
-35 Reduced 2.35%
1,452 $329,000
Q3 2024

Nov 05, 2024
SELL
$221.47 - $242.41 $15,724 - $17,211
-71 Reduced 4.56%
1,487 $358,000
Q2 2024

Aug 02, 2024
BUY
$225.07 - $246.17 $1,800 - $1,969
8 Added 0.52%
1,558 $364,000
Q1 2024

Apr 26, 2024
BUY
$233.45 - $247.73 $8,637 - $9,166
37 Added 2.45%
1,550 $383,000
Q4 2023

Feb 06, 2024
SELL
$232.24 - $267.23 $8,592 - $9,887
-37 Reduced 2.39%
1,513 $368,000
Q3 2023

Nov 06, 2023
SELL
$254.9 - $283.59 $9,686 - $10,776
-38 Reduced 2.39%
1,550 $400,000
Q2 2023

Aug 01, 2023
SELL
$238.39 - $265.32 $31,944 - $35,552
-134 Reduced 7.78%
1,588 $419,000
Q1 2023

Apr 26, 2023
SELL
$229.71 - $259.35 $11,485 - $12,967
-50 Reduced 2.82%
1,722 $426,000
Q4 2022

Feb 02, 2023
SELL
$218.29 - $256.91 $4,365 - $5,138
-20 Reduced 1.12%
1,772 $450,000
Q3 2022

Nov 02, 2022
SELL
$51.03 - $264.23 $9,950 - $51,524
-195 Reduced 9.81%
1,792 $400,000
Q2 2022

Aug 03, 2022
SELL
$234.74 - $275.42 $29,811 - $34,978
-127 Reduced 6.01%
1,987 $490,000
Q1 2022

May 03, 2022
SELL
$243.64 - $270.48 $25,582 - $28,400
-105 Reduced 4.73%
2,114 $562,000
Q4 2021

Feb 03, 2022
SELL
$230.08 - $250.94 $76,616 - $83,563
-333 Reduced 13.05%
2,219 $558,000
Q3 2021

Nov 05, 2021
BUY
$232.72 - $256.47 $43,285 - $47,703
186 Added 7.86%
2,552 $627,000
Q2 2021

Aug 06, 2021
BUY
$232.65 - $254.58 $24,893 - $27,240
107 Added 4.74%
2,366 $575,000
Q1 2021

May 06, 2021
BUY
$232.09 - $256.88 $40,383 - $44,697
174 Added 8.35%
2,259 $549,000
Q4 2020

Feb 10, 2021
SELL
$221.92 - $245.94 $23,745 - $26,315
-107 Reduced 4.88%
2,085 $522,000
Q3 2020

Nov 04, 2020
BUY
$215.77 - $276.76 $13,809 - $17,712
64 Added 3.01%
2,192 $510,000
Q2 2020

Aug 06, 2020
SELL
$219.9 - $263.41 $71,247 - $85,344
-324 Reduced 13.21%
2,128 $510,000
Q1 2020

Apr 29, 2020
SELL
$195.69 - $279.01 $60,272 - $85,935
-308 Reduced 11.16%
2,452 $564,000
Q4 2019

Feb 04, 2020
SELL
$236.45 - $266.82 $3,546 - $4,002
-15 Reduced 0.54%
2,760 $751,000
Q3 2019

Nov 01, 2019
SELL
$230.58 - $256.08 $45,193 - $50,191
-196 Reduced 6.6%
2,775 $702,000
Q2 2019

Jul 22, 2019
BUY
$217.4 - $246.08 $83,699 - $94,740
385 Added 14.89%
2,971 $748,000
Q1 2019

Apr 25, 2019
SELL
$206.05 - $248.17 $41,622 - $50,130
-202 Reduced 7.25%
2,586 $646,000
Q4 2018

Jan 28, 2019
SELL
$204.73 - $257.93 $34,804 - $43,848
-170 Reduced 5.75%
2,788 $629,000
Q3 2018

Oct 31, 2018
SELL
$233.07 - $256.0 $55,936 - $61,440
-240 Reduced 7.5%
2,958 $0
Q2 2018

Jul 30, 2018
SELL
$208.1 - $233.85 $63,262 - $71,090
-304 Reduced 8.68%
3,198 $766,000
Q1 2018

Apr 30, 2018
BUY
$205.46 - $240.27 $439,478 - $513,937
2,139 Added 156.93%
3,502 $759,000
Q4 2017

Jan 17, 2018
SELL
$189.0 - $222.64 $83,160 - $97,961
-440 Reduced 24.4%
1,363 $291,000
Q3 2017

Nov 06, 2017
BUY
$186.89 - $198.9 $28,594 - $30,431
153 Added 9.27%
1,803 $354,000
Q2 2017

Aug 07, 2017
BUY
N/A
1,650
1,650 $322,000

Others Institutions Holding BDX

# of Institutions
1,796
Shares Held
258M
Call Options Held
1.23M
Put Options Held
866K
View Full List

About BECTON DICKINSON & CO

BDX Quotes by TradingView
  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $64.1B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track First National Trust CO Portfolio

Follow First National Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First National Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on First National Trust CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email